These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 28750410)
1. Loss of the Protein Cystathionine β-Synthase During Kidney Injury Promotes Renal Tubulointerstitial Fibrosis. Yuan X; Zhang J; Xie F; Tan W; Wang S; Huang L; Tao L; Xing Q; Yuan Q Kidney Blood Press Res; 2017; 42(3):428-443. PubMed ID: 28750410 [TBL] [Abstract][Full Text] [Related]
2. [Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction]. Zhao DA; Liu J; Huang Q; Han ZM Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):903-8. PubMed ID: 24131846 [TBL] [Abstract][Full Text] [Related]
3. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2. Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro. Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422 [TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition. Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway. Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2. He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506 [TBL] [Abstract][Full Text] [Related]
8. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril. Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615 [TBL] [Abstract][Full Text] [Related]
9. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation. Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914 [TBL] [Abstract][Full Text] [Related]
10. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. Jung KJ; Jang HS; Kim JI; Han SJ; Park JW; Park KM Biochim Biophys Acta; 2013 Dec; 1832(12):1989-97. PubMed ID: 23846016 [TBL] [Abstract][Full Text] [Related]
11. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114 [TBL] [Abstract][Full Text] [Related]
12. Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction. Liu C; Mei W; Tang J; Yuan Q; Huang L; Lu M; Wu L; Peng Z; Meng J; Yang H; Shen H; Lv B; Hu G; Tao L PLoS One; 2015; 10(6):e0129283. PubMed ID: 26042668 [TBL] [Abstract][Full Text] [Related]
13. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice. Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Mizuno S; Matsumoto K; Nakamura T Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391 [TBL] [Abstract][Full Text] [Related]
16. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro. Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy. Du C; Ren Y; Yao F; Duan J; Zhao H; Du Y; Xiao X; Duan H; Shi Y Int J Biochem Cell Biol; 2017 Sep; 90():17-28. PubMed ID: 28733250 [TBL] [Abstract][Full Text] [Related]
18. GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression. Xiao Y; Liu J; Peng Y; Xiong X; Huang L; Yang H; Zhang J; Tao L PLoS One; 2016; 11(9):e0160855. PubMed ID: 27602565 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction. Wang L; Lee JY; Kwak JH; He Y; Kim SI; Choi ME Am J Physiol Renal Physiol; 2008 Mar; 294(3):F508-17. PubMed ID: 18094035 [TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat. Mazzei LJ; García IM; Altamirano L; Docherty NG; Manucha W Am J Nephrol; 2012; 35(2):103-13. PubMed ID: 22212364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]